Alicante Science Park Foundation (PCA) and Laminar Pharmaceuticals have signed today the contract by which the biotechnology company is linked to the PCA....
In 2020, biologist Gema Malet Engra joined our company after a successful 15-year career in fundamental and applied research in Oncology at several international research centers. ...
Laminar Pharma, la biotecnológica española valorada en 70 millones de euros a punto de dar el salto a bolsa, quiere ser "un punto de inflexión en la terapia del cáncer" ...
Women’s contributions to science and technology have always been lower than men’s due to the social and sexual separation in these jobs. ...
In 2020, biologist Gema Malet Engra joined the biotechnology company Laminar Pharmaceuticals after a successful 15-year career in fundamental and applied research in Oncology at several international research centers. ...
On the last day of February — a month known for having a ‘rare’ number of days — we commemorate Rare Disease Day to celebrate their strength, to share their stories and to champion research that will improve these patients’ lives....
Fellow Funders y Nowture, aliados por la biotecnología ...
Meliterapia: las medicinas del futuro ...
Esta startup española podría revolucionar las terapias para tratar el cáncer infantil ...
On January 2021, the researchers whose projects have received funding from the CAIB 2020 call of the Balearic Government for the promotion of hiring of research staff were announced: Ramón Román Roldán has been selected, and he will join the Research Unit of Laminar Pharma....